s-nitroso-n-acetylpenicillamine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horikawa, Y; Ishikawa, J; Kanakura, Y; Kanayama, Y; Matsumura, I; Matsuzawa, Y; Nakao, H; Nishiura, T; Ogawa, M; Okajima, Y; Tomiyama, Y; Yoshida, H; Yoshimura, M | 1 |
1 other study(ies) available for s-nitroso-n-acetylpenicillamine and Chronic Fatigue and Immune Dysfunction Syndrome
Article | Year |
---|---|
Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome.
Topics: Adjuvants, Immunologic; Adult; Arginine; Base Sequence; Case-Control Studies; DNA Primers; Enzyme Inhibitors; Fatigue Syndrome, Chronic; Female; Humans; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Subsets; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Penicillamine; S-Nitroso-N-Acetylpenicillamine | 1998 |